Sugarlogix is an early-stage biotech startup based in Oakland, California, specializing in the development of yeast-based technologies to produce human milk oligosaccharides (HMOs). These HMOs are rare, functional sugars naturally found in human breast milk and are not sweet but carry significant health benefits. They are the most effective prebiotic for infants, aiding in balancing the gut microbiome, which supports the immune system and neurological development. The company primarily serves the infant formula market, aiming to provide better nutrition for formula-fed babies. Sugarlogix operates in the biotech and nutrition sectors, focusing on leveraging advanced yeast fermentation techniques to create these beneficial sugars. The business model revolves around producing and selling HMOs to infant formula manufacturers, generating revenue through product sales.

Keywords: biotech, human milk oligosaccharides, infant formula, prebiotics, gut microbiome, immune support, neurological development, yeast-based technology, nutrition, Oakland.